BDNF and major depressive disorder: Nevertheless, it is still unclear whether the increased peripheral expression of the neurotrophin can be considered as a marker of the actual depressive episode (DE) itself, its structural domains (affective, cognitive or somatic disturbances), severity, clinical subtype or mentioned elevation is associated with the characteristics of the course of MDD (duration, number of episodes, etc.).